UW-Madison researchers have found in a study of monkeys that casual contact through saliva is not enough for the virus to move between hosts.
research
Stem cell advance brings bioengineered arteries closer to reality
New techniques have produced, for the first time, functional arterial cells at both the quality and scale to be relevant for disease modeling and clinical application.
Researchers make headway toward understanding Alexander disease
The new finding by the UW-Madison Waisman Center could change the way scientists think about and try to solve the rare, fatal disorder.
Study shows stem cells fiercely abide by innate developmental timing
Scientists from the Morgridge Institute for Research and UW-Madison are studying whether stem cell differentiation rates can be accelerated in the lab and made available to patients faster.
Listeria may be serious miscarriage threat early in pregnancy
Listeria makes about 1,600 Americans sick each year — a relatively small number, but a group heavy on newborn babies and older adults with undeveloped or weak immune systems.
From mice, clues to microbiome’s influence on metabolic disease
The microorganisms that reside in the gut work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of diabetes.
Calorie restriction lets monkeys live long and prosper
Settling a persistent scientific controversy, a long-awaited report shows that restricting calories does indeed help rhesus monkeys live longer, healthier lives.
Morgridge–UW project investigates tissue-engineered arteries for transplant
The prospect of creating artery “banks” could transform treatment of many common heart and vascular ailments. But it’s a big leap from concept to reality.
Madison startup advances three-in-one cancer drug rooted at UW
The first target for Co-D is angiosarcoma, a rare and lethal cancer that arises from blood vessels.
Stem cell ‘heart patch’ moves closer to clinic
The promise of stem cells to treat cardiovascular disease may soon be a step closer to overcoming the last big hurdle before trials in human patients.